Results 351 to 358 of about 66,239 (358)

The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor

Nature Reviews Drug Discovery, 2010
exaly  

Attempted suicide with rivaroxaban

Annals of Hematology, 2016
Sigal Nakav, Dorit Blickstein, Dorit Blickstein, Saaid Younes   +3 more
openaire   +2 more sources

Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Lancet, The, 2015
Jeffrey B Washam, Daniel E Singer, Graeme J Hankey   +2 more
exaly  

Oral rivaroxaban for symptomatic venous thromboembolism.

New England Journal of Medicine, 2011
G. Landman, R. Gans
semanticscholar   +1 more source

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial

Lancet, The, 2009
exaly  

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

European Heart Journal, 2015
Riccardo Cappato, Gerald V Naccarelli, Johan Vijgen   +2 more
exaly  

The perils of rivaroxaban in younger patients

Thrombosis Research, 2016
openaire   +3 more sources

Clinical Pharmacokinetic and Pharmacodynamic Profile of Rivaroxaban

Clinical Pharmacokinetics, 2013
exaly